147,800 Colgate-Palmolive Company $CL Shares Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

Posted by George Bondi on Oct 31st, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 12.2% during the third quarter, HoldingsChannel.com reports. The firm owned 1,359,738 shares of the company’s stock after acquiring an additional 147,800 shares during the quarter. Colgate-Palmolive makes up about 0.7% of VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings, making the stock its 20th biggest holding. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Colgate-Palmolive were worth $116,013,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Partners Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $419,000. Soltis Investment Advisors LLC increased its position in shares of Colgate-Palmolive by 20.0% in the third quarter. Soltis Investment Advisors LLC now owns 16,140 shares of the company’s stock worth $1,377,000 after purchasing an additional 2,691 shares during the period. Founders Financial Securities LLC increased its position in shares of Colgate-Palmolive by 40.9% in the third quarter. Founders Financial Securities LLC now owns 4,191 shares of the company’s stock worth $358,000 after purchasing an additional 1,216 shares during the period. United Asset Strategies Inc. increased its position in shares of Colgate-Palmolive by 3.4% in the third quarter. United Asset Strategies Inc. now owns 136,350 shares of the company’s stock worth $11,633,000 after purchasing an additional 4,534 shares during the period. Finally, Choreo LLC raised its stake in Colgate-Palmolive by 9.7% in the third quarter. Choreo LLC now owns 38,890 shares of the company’s stock valued at $3,318,000 after purchasing an additional 3,441 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Colgate-Palmolive Stock Performance

NYSE CL opened at $95.35 on Friday. The firm’s fifty day moving average price is $89.54 and its two-hundred day moving average price is $89.65. The stock has a market cap of $76.01 billion, a PE ratio of 24.39, a PEG ratio of 4.51 and a beta of 0.33. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. During the same period in the prior year, the business earned $0.91 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s payout ratio is currently 84.13%.

Insider Buying and Selling

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer owned 64,901 shares of the company’s stock, valued at $5,974,137.05. This represents a 13.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director John Cahill sold 4,170 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 175,191 shares of company stock worth $16,110,903 in the last 90 days. Insiders own 0.43% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CL. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $104.00 price objective on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Barclays increased their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Jefferies Financial Group reissued a “hold” rating and issued a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Bank of America dropped their target price on shares of Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating for the company in a research report on Friday, October 9th. Finally, BNP Paribas Exane cut their price target on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating for the company in a report on Monday, September 28th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $98.56.

Read Our Latest Research Report on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.